VISTA
Anualidades
Lista
2023
2022
2021
2020
2019
2018
2017
2016
2015
TOTAL Nº PUBLICACIONES:
5
PUBLICACIONES EN REVISTAS
Montero, Juan Carlos, del Carmen, Sofia, Abad, Mar, Sayagues, Jose M., Barbachano, Antonio, Fernandez-Barral, Asuncion, Munoz, Alberto, Pandiella, Atanasio.
An amino acid transporter subunit as an antibody-drug conjugate target in colorectal cancer.
J EXP CLIN CANC RES 42 -. 9 ago 2023. . . F.I.:11,300
[doi:10.1186/s13046-023-02784-0]
Sanchez-Fdez, A, Matilla-Almazan, S, del Carmen, S, Abad, M, Arconada-Luque, E, Jimenez-Suarez, J, Chinchilla-Tabora, LM, Ruiz-Hidalgo, MJ, Sanchez-Prieto, R, Pandiella, A, Esparis-Ogando, A.
Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications.
EXP MOL MED 55 1247-1257. 1 jun 2023. 1 jun 2023. . F.I.:12,800
[doi:10.1038/s12276-023-01008-x]
Sanchez-Fdez, A, Matilla-Almazan, S, Montero, JC, Del Carmen, S, Abad, M, Garcia-Alonso, S, Bhattacharya, S, Calar, K, de la Puente, P, Ocana, A, Pandiella, A, Esparis-Ogando, A.
The WNK1-ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib.
CLIN TRANSL MED 13 -. 1 abr 2023. . . F.I.:10,600
[doi:10.1002/ctm2.1217]
Gandullo-Sanchez, L, Pandiella, A.
An anti-EGFR antibody-drug conjugate overcomes resistance to HER2-targeted drugs.
CANCER LETT 554 -. 1 feb 2023. 1 dic 2022. . F.I.:9,700
[doi:10.1016/j.canlet.2022.216024]
Spinola-Lasso, E, Montero, JC, Jimenez-Monzon, R, Estevez, F, Quintana, J, Guerra, B, Elokely, KM, Leon, F, del Rosario, H, Fernandez-Perez, L, Lopez, MR, Diaz-Chico, BN, McNaughton-Smith, G, Pandiella, A, Diaz-Chico, JC.
Chemical-proteomics Identify Peroxiredoxin-1 as an Actionable Target in Triple-negative Breast Cancer.
INT J BIOL SCI 19 1731-1747. 1 ene 2023. . . F.I.:9,200
[doi:10.7150/ijbs.78554]
Previous
1
Next
Nº de Artículos por página:
10
25
50
100